Asthma

Showing NaN - NaN of 151

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Asthma Trial in Worldwide (Beclomethasone dipropionate BAI, Placebo BAI, albuterol/salbutamol 90 mcg)

Completed
  • Asthma
  • Beclomethasone dipropionate BAI
  • +4 more
  • Hoover, Alabama
  • +101 more
Nov 5, 2021

Asthma Trial in Huntington Beach, Raleigh, San Antonio (Fluticasone Propionate MDPI, Fluticasone Propionate/Salmeterol MDPI,

Completed
  • Asthma
  • Fluticasone Propionate MDPI
  • +2 more
  • Huntington Beach, California
  • +2 more
Nov 5, 2021

Asthma Trial in Worldwide (Fluticasone Propionate, Fluticasone Propionate/Salmeterol, Placebo MDPI)

Completed
  • Asthma
  • Fluticasone Propionate
  • +2 more
  • Birmingham, Alabama
  • +117 more
Nov 5, 2021

Asthma Trial in Worldwide (Reslizumab, Placebo)

Completed
  • Asthma
  • Birmingham, Alabama
  • +225 more
Nov 5, 2021

Asthma Trial in United States (Albuterol Sulfate)

Completed
  • Asthma
  • Albuterol Sulfate
  • Litchfield Park, Arizona
  • +43 more
Nov 5, 2021

Asthma Trial in Worldwide (Benralizumab (Medi-563), Placebo)

Completed
  • Asthma
  • Benralizumab (Medi-563)
  • Placebo
  • Birmingham, Alabama
  • +212 more
Oct 20, 2021

Asthma Trial in United States (Fevipiprant)

Terminated
  • Asthma
  • Minneapolis, Minnesota
  • +5 more
Oct 7, 2021

Asthma Trial in Worldwide (MSTT1041A, Placebo)

Completed
  • Asthma
  • Birmingham, Alabama
  • +137 more
Oct 6, 2021

Asthma Trial in Worldwide (QAW039, Placebo)

Completed
  • Asthma
  • Andalusia, Alabama
  • +141 more
Oct 6, 2021

Asthma Trial in Worldwide (GB001, Placebo)

Completed
  • Asthma
  • Birmingham, Alabama
  • +116 more
Aug 20, 2021

Asthma Trial in Worldwide (Tezepelumab (APFS), Tezepelumab (AI))

Completed
  • Asthma
  • Tezepelumab (APFS)
  • Tezepelumab (AI)
  • Hoover, Alabama
  • +35 more
Jul 9, 2021

Asthma Trial in Worldwide (RELVAR/BREO, Salbutamol, Smart phone app)

Completed
  • Asthma
  • Aventura, Florida
  • +65 more
Mar 17, 2021

Asthma Trial in Worldwide (FF/UMEC/VI (100/31.25/25) mcg, FF/UMEC/VI (100/62.5/25) mcg, FF/UMEC/VI (200/31.25/25) mcg)

Completed
  • Asthma
  • FF/UMEC/VI (100/31.25/25) mcg
  • +10 more
  • Birmingham, Alabama
  • +408 more
Feb 26, 2021

Serum Resistin in Asthmatics asPotential Marker of Systemic

Completed
  • Asthma
    • San Antonio, Texas
      Wilford Hall Medical Center
    Jan 14, 2021

    Asthma Trial in Worldwide (AZD7594 DPI 55µg/50µg., AZD7594 DPI 99 µg/90 µg, AZD7594 DPI 198 µg/180 µg)

    Completed
    • Asthma
    • AZD7594 DPI 55μg/50μg.
    • +6 more
    • Sheffield, Alabama
    • +93 more
    Nov 4, 2020

    Asthma Trial in Worldwide (QAW039 150 mg, QAW039 450 mg, Placebo)

    Terminated
    • Asthma
    • QAW039 150 mg
    • +2 more
    • Birmingham, Alabama
    • +347 more
    Sep 14, 2020

    Asthma Trial in United States (GP MDI 28.8 µg, GP MDI 14.4 µg, GP MDI 7.2 µg)

    Completed
    • Asthma
    • GP MDI 28.8 μg
    • +4 more
    • Birmingham, Alabama
    • +231 more
    Aug 11, 2020

    Asthma Trial in Worldwide (QAW039, Placebo)

    Completed
    • Asthma
    • Birmingham, Alabama
    • +232 more
    May 4, 2020

    Diabetes, Asthma, Pulmonary Disease, Chronic Obstructive Trial in Worldwide (Human Insulin Inhalation Powder, injected insulin)

    Completed
    • Diabetes Mellitus
    • +2 more
    • Human Insulin Inhalation Powder
    • injected insulin
    • Montgomery, Alabama
    • +100 more
    Sep 9, 2019

    Asthma Trial in Worldwide (Benralizumab)

    Completed
    • Asthma
    • Benralizumab
    • Andalusia, Alabama
    • +430 more
    Aug 5, 2019

    Asthma Trial in United States (ELLIPTA DPI, GSK MDI, AZ MDI)

    Completed
    • Asthma
    • ELLIPTA DPI
    • +2 more
    • Huntington Beach, California
    • +19 more
    Jun 24, 2019

    Asthma Trial in Worldwide (FP, LABA, LTRA)

    Completed
    • Asthma
    • Birmingham, Alabama
    • +99 more
    Apr 5, 2019

    Asthma Trial in Worldwide (Tralokinumab, Placebo)

    Completed
    • Asthma
    • Tralokinumab
    • Placebo
    • New Haven, Connecticut
    • +50 more
    Feb 27, 2019

    Asthma Trial in Canada, United States (Benralizumab)

    Completed
    • Asthma
    • Benralizumab
    • Northridge, California
    • +24 more
    Oct 30, 2018